The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT.
 
Noah M. Hahn
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Health Advances; Inovio Pharmaceuticals; Merck; Oncogenex; Pieris Pharmaceuticals
Research Funding - Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Heat Biologics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Principa Biopharma (Inst)
 
Sam S. Chang
Consulting or Advisory Role - Altor BioScience; BioCancell; MDxHealth
 
Maxwell Meng
Honoraria - Auris
Research Funding - Genentech
 
Neal D. Shore
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Myovant Sciences; Pfizer; Tolmar
Speakers' Bureau - Bayer; Dendreon; Janssen
 
Badrinath R. Konety
Consulting or Advisory Role - MDxHealth
Research Funding - FKD Therapies (Inst); Genomic Health (Inst); Photocure (Inst); Roche/Genentech (Inst)
 
Gary D. Steinberg
Honoraria - Baxter; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; MDxHealth; Merck; Photocure; Roche/Genentech; Taris Biomedical; Telesta Therapeutics
Consulting or Advisory Role - Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; MDxHealth; Merck; Natera; photocure; Roche/Genentech; Taris BioMedical
 
Juergen E. Gschwend
Honoraria - Bayer Schering Pharma; Janssen-Cilag
Consulting or Advisory Role - Bayer Schering Pharma; Janssen-Cilag
 
Hiroyuki Nishiyama
Consulting or Advisory Role - Bayer Yakuhin; Chugai Pharma; Janssen; Lilly; MSD
Speakers' Bureau - Chugai Pharma; MSD
Research Funding - Astellas Pharma (Inst); Ono Pharmaceutical (Inst); Takeda (Inst)
 
Juan Palou Redorta
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
John Arthur Taylor
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Ferring
 
Ayanbola Elegbe
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Alexandre Lambert
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Li Zhu
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Yuko Ishii
Employment - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Millennium; Takeda
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb
Other Relationship - Agios
 
Toshiki Maeda
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Bradley Raybold
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Gary Grossfeld
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Bruce S. Fischer
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Mark Rutstein
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Alfred Witjes
Consulting or Advisory Role - BioCancell; Bristol-Myers Squibb; Cepheid; Nucleix; Spectrum Pharmaceuticals; taris; Tocagen
Research Funding - cepheid (Inst); Nucleix (Inst); taris (Inst)